Hopp til innhold
NHI.no
Annonse

Ebolainfeksjon: Diagnostikk

Innhold i artikkelen

Diagnosen stilles ved påvisning av ebolavirus i blodet. Det kreves spesialutstyr for å gjennomføre denne analysen.

Diagnosen kan være vanskelig å stille kun ut fra symptomene tidlig i sykdomsforløpet. Symptomene de første dagene er ofte uspesifikke og ligner andre infeksjonssykdommer som influensa og malaria.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Ebola . Referanselisten for dette dokumentet vises nedenfor

  1. Malvy D, McElroy AK, de Clerck H, Günther S, van Griensven J. Ebola virus disease. Lancet. 2019;393(10174):936-948. PubMed
  2. Folkehelseinstituttet. Fakta om ebola og ebolavirussykdom. FHI okt. 2014. [url]http://www.fhi.no/tema/ebola/fakta-om-ebola[/url].,m.,m.,m
  3. World Health Organisation. Situation report. Ebola virus disease. 10 June 2016. apps.who.int
  4. WHO media centre. Final trial results confirm Ebola vaccine provides high protection against disease. Dec. 23, 2016 www.who.int
  5. European Centre for Disease Prevention and Control. Ebola outbreak in Uganda, as of 13 December 2022. Published 16 Dec 2022. www.ecdc.europa.eu
  6. WHO media centre. Key facts. Ebola virus disease, last updated 23 February 2021. www.who.int
  7. Becquart P, Wauquier N, Mahlakõiv T, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010; 5: e9126. PubMed
  8. Bah EI, Lamah MC, Fletcher T, et al. Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea. N Engl J Med. 2014 Nov 5. PMID: 25372658 PubMed
  9. Richardson ET, Kelly JD, Barrie MB, et al. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.. PLoS Negl Trop Dis 2016; 11: e0005087. pmid:27846221 PubMed
  10. Deen GF, Knust B, Broutet N, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Preliminary Report. New Engl J Med 2015. doi:10.1056/NEJMoa1511410 DOI
  11. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcome in patients with ebola in Sierra Leone. N Engl J Med 2014. doi:10.1056/NEJMoa1411680 DOI
  12. Mulangu S, Dodd LE, Davey RT, et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med 2019; 381: 2293-303. pmid:31774950 PubMed
  13. UpToDate.com; Bray M, Chertow DS: Treatment and prevention of Ebola virus disease. Sist oppdatert 28. nov. 2016. www.uptodate.com
  14. Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2016 Dec; Epub ahead of print: S0140-6736(16)32621-6. pmid:28017403 PubMed
  15. PREVAC Study Team. Randomized Trial of Vaccines for Zaire Ebola Virus Disease. N Engl J Med 2022; 387: 2411-2424. pmid:36516078 PubMed
  16. Bowen L, Smith B, Steinbach S, et al. Survivors of Ebola virus disease have persistent neurologic deficits. AAN Annual Meeting Abstract . www.aan.com
  17. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola Virus Disease in Guinea — Preliminary Report. N Eng Journ Med 2014. doi:10.1056/NEJMoa1404505 DOI
  18. Thom R, Tipton T, Strecker T, et al. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. Lancet Infect Dis 2021; 21: 507-16. pmid:33065039 PubMed
Annonse
Annonse